// App-Quantinova.ai

276 : Enhancing standard chemotherapy response by targeted inhibition of MAPK signaling pathways in experimental pancreatic cancer

Researchers

Presenter

  • Niranjan Awasthi

Principal Investigators

  • Sheena Monahan

  • Margaret A. Schwarz

  • Roderich E. Schwarz

Medical Centers

  • Indiana University School of Medicine South Bend, South Bend, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Mitogen-activated protein kinase

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

  • Trametinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved